Come Learn About New Funding Opportunities for Small Businesses

POST EVENT UPDATE AND PRESENTATION:  Michael Weingarten, Director of the NCI SBIR Development Center, presented to more than 75 members of the Houston life science community on August 1st about the new SBIR Bridge Award Program.  His presentation slides are attached here: NCI SBIR Bridge Program

At this event the NCI will share a list of 18 new oncology contract topics that will be solicited in mid-August.   NCI  will also discuss in detail the new SBIR  Bridge Award Program which more than triples the amount of funding available to applicants through the NCI SBIR Program.  The new Bridge Award is designed to support the next stage of development for previously funded NIH SBIR Phase II cancer therapy and imaging projects. 

The Phase II Bridge Award will help:

• “Bridge” the funding gap, known as the “Valley of Death,” that currently exists between the end of the SBIR Phase II award and the next round of financing needed to advance a promising cancer therapy or imaging technology toward commercialization;
• Incentivize partnerships between NIH's SBIR Phase II awardees and third-party investors and/or strategic partners.

Additional Funding Opportunities   
The NCI SBIR & STTR Programs have a number of upcoming funding announcements for prospective Phase I, Phase II, and Bridge Award applicants. The next application deadlines are August 5, September 19, and September 24. [Learn more]

This event will also include practical advice on strategies for developing successful applications for SBIR and STTR funding. Entrepreneurs and researchers in the biotechnology and pharmaceutical industries who want to learn about funding available through the NCI SBIR and STTR Programs are encouraged to attend.

To participate in the SBIR Program:

• The Small Business Concern (SBC) must be an organized for-profit business of 500 employees or fewer (including affiliates), located in the United States
• The SBC must be:
  • At least 51 percent U.S.-owned by individuals and independently operated; OR
  • At least 51 percent owned and controlled by another for-profit business concern that is at least 51 percent U.S.-owned by individuals and independently operated
• The Principal Investigator's primary employment must be with the SBC at the time of award and for the duration of the project period

Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov

The goal of the National Cancer Institute is to eliminate the suffering and death due to cancer. The SBIR & STTR Programs are NCI's engines of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. For more information, please email ncisbir@mail.nih.gov or visit http://sbir.cancer.gov.

Pricing